[1]SIEGEL RL, MILLER KD, JEMAL A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66 (1) :7-30.
|
[2]CHOU R, CUEVAS C, FU R, et al.Imaging techniques for the diagnosis of hepatocellular carcinoma:A systematic review and meta-analysis[J].Ann Intern Med, 2015, 162 (10) :697-711.
|
[3]ZHANG CY, FU Y, LI XD, et al.Advances in imaging diagnosis of liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1266-1269. (in Chinese) 张春雨, 付宇, 李晓东, 等.肝癌的影像学诊断进展[J].临床肝胆病杂志, 2017, 33 (7) :1266-1269.
|
[4]International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:A report of the international consensus group for hepatocellular neoplasia[J].Hepatology, 2009, 49 (2) :658-664.
|
[5]LIU J, CHENG Y, HE M, et al.Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein[J].Gynecol Endocrinol, 2014, 30 (6) :461-465.
|
[6]SONG JH, YU DX, FANG JJ, et al.Specific MR imaging of hepatocellular carcinoma using AFP-targeted USPIO molecular probe[J].Chin J Hepatobiliary Surg, 2012, 18 (8) :618-622. (in Chinese) 宋吉慧, 于德新, 方娟娟, 等.甲胎蛋白靶向USPIO分子探针在肝癌特异性磁共振成像中的价值[J].中华肝胆外科杂志, 2012, 18 (8) :618-622.
|
[7]EFFENDI K, SAKAMOTO M.Molecular pathology in early hepatocarcinogenesis[J].Oncology, 2010, 78 (2) :157-160.
|
[8]MA L, JI L, YU Y, et al.Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma[J].Discov Med, 2015, 19 (102) :7-14.
|
[9] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
[10]BHARALI DJ, MOUSA SA.Emerging nanomedicines for early cancer detection and improved treatment:Current perspective and future promise[J].Pharmacol Ther, 2010, 128 (2) :324-335.
|
[11]OGHABIAN MA, FARAHBAKHSH NM.Potential use of nanoparticle based contrast agents in MRI:A molecular imaging perspective[J].J Biomed Nanotechnol, 2010, 6 (3) :203-213.
|
[12]MA KS, JIANG JY.Application of tissue-specific magnetic resonance imaging contrast agent gadolinium ethoxybenzyl dimeglumine on precision hepatic surgery[J].Chin J Dig Surg, 2017, 16 (2) :124-129. (in Chinese) 马宽生, 蒋家云.钆塞酸二钠增强MRI检查在精准肝脏外科中的应用[J].中华消化外科杂志, 2017, 16 (2) :124-129.
|
[13]SUN Y, ZHENG YY, WU W, et al.Influence of superparamagnetic iron oxide loaded polymermicrospheres on enhanced MRI for liver cancer of rabbits[J].Chin J Med Imaging Technol, 2012, 28 (8) :1445-1448. (in Chinese) 孙阳, 郑元义, 吴伟, 等.载超顺磁性氧化铁高分子微球对兔肝癌MR成像效果的影响[J].中国医学影像技术, 2012, 28 (8) :1445-1448.
|
[14]ISLAM T, JOSEPHSON L.Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles[J].Cancer Biomark, 2009, 5 (2) :99-107.
|
[15]YAMAGUCHI R, YANO H, NAKASHIMA O, et al.Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2006, 21 (1 Pt 1) :152-160.
|
[16]MORITA Y, MORITA N, HATA K, et al.Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117 (4) :502-510.
|
[17]CHEN Y, ZHOU Q, LI X, et al.Ultrasmall paramagnetic iron oxide nanoprobe targeting epidermal growth factor receptor for in vivo magnetic resonance imaging of hepatocellular carcinoma[J].Bioconjug Chem, 2017, 28 (11) :2794-2803.
|
[18]JIANG AL, GUO ZB, DING ZX.Expression and significance of VEGF-C in human hepatocellular carcinoma tissues[J].Chin J Cancer Prev Treat, 2009, 16 (13) :1006-1008. (in Chinese) 姜爱莲, 郭子博, 丁兆习.VEGF-C在人原发性肝细胞肝癌中的表达及意义[J].中华肿瘤防治杂志, 2009, 16 (13) :1006-1008.
|
[1] | Wei YU, Chengbin ZHANG, Yan MA. A case of primary carcinosarcoma of the liver[J]. Journal of Clinical Hepatology, 2021, 37(12): 2890-2890. doi: 10.3969/j.issn.1001-5256.2021.12.030 |
[2] | Jiamin ZHAO, Zhiyuan CHEN, Chengliang DING, Lili YUAN, Jingjing QIAN, Chunyang XU, Lingyun ZUO. Primary biliary cholangitis with hepatic angiosarcoma: A case report[J]. Journal of Clinical Hepatology, 2021, 37(10): 2411-2413. doi: 10.3969/j.issn.1001-5256.2021.10.031 |
[3] | Mengnan LI, Gongchen WANG, Zhiming ZHANG. A case of hepatic angiosarcoma with Kasabach-Merritt syndrome[J]. Journal of Clinical Hepatology, 2021, 37(11): 2646-2648. doi: 10.3969/j.issn.1001-5256.2021.11.032 |
[4] | Huijun WANG, Jianxiang NIU, Xiaoyan XU, Weihua ZHENG, Pengfei LI, Yibo LIU, Junjing ZHANG. A case of primary splenic angiosarcoma[J]. Journal of Clinical Hepatology, 2021, 37(11): 2655-2657. doi: 10.3969/j.issn.1001-5256.2021.11.036 |
[5] | Li Dong, Luo TianYang, Ran YaWei. Value of contrast-enhanced computed tomography and magnetic resonance imaging in diagnosis of residual or recurrent lesion after transcatheter arterial chemoembolization in hepatocellular carcinoma:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2214-2219. doi: 10.3969/j.issn.1001-5256.2019.10.017 |
[6] | Zhang XueWen, Dai ChaoLiu. Primary hepatic angiosarcoma in the elderly: A case report and literature review[J]. Journal of Clinical Hepatology, 2019, 35(3): 605-607. doi: 10.3969/j.issn.1001-5256.2019.03.031 |
[7] | Zhu XiXun, Li ZhiWei, Zheng Yu. A case of primary hepatic angiosarcoma with splenic metastasis and rupture[J]. Journal of Clinical Hepatology, 2019, 35(3): 608-610. doi: 10.3969/j.issn.1001-5256.2019.03.032 |
[8] | Wang ShuPeng, Han KaiZe, Wang Wu, Yang Yang, Liu YaHui. Spontaneous rupture of splenic angiosarcoma: 2 cases report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2670-2671. doi: 10.3969/j.issn.1001-5256.2018.12.035 |
[9] | Huang Lu, Lu LiJian. CT and MRI manifestations of liver fluke granuloma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1548-1551. doi: 10.3969/j.issn.1001-5256.2017.08.028 |
[10] | Du XiaoFeng, Ma ZhouPeng, Lin GuanSheng, He Hui, Tang YaRong, Wu JianMing. CT diagnosis and differentiation of nodular/mass-type hepatic lymphoma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1492-1496. doi: 10.3969/j.issn.1001-5256.2017.08.016 |
[11] | Zhang YiWei, Zhang Wei, Liu Feng, Liu YaHui. Laparoscopic splenectomy in treatment of splenic angiosarcoma: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 744-745. doi: 10.3969/j.issn.1001-5256.2017.04.034 |
[12] | Li XinMing, Quan XianYue, Tan ShuPing. Imaging feature of rare liver neoplasms[J]. Journal of Clinical Hepatology, 2016, 32(12): 2289-2294. doi: 10.3969/j.issn.1001-5256.2016.12.012 |
[13] | Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014 |
[14] | Ke JianJi, Liu FeiQi, Zhang Wei, Liu YaHui. One case of huge hepatic angiosarcoma[J]. Journal of Clinical Hepatology, 2015, 31(11): 1902-1903. doi: 10.3969/j.issn.1001-5256.2015.11.034 |
[15] | Liu BinBin, Wang YuHong. Values of MRI and CT in diagnosis and treatment of acute pancreatitis[J]. Journal of Clinical Hepatology, 2013, 29(7): 489-491. doi: 1001-5256 (2013) 07-0489-03 |
[16] | Yan FuHua, Luo XianFu. Research progress in CT and MR for quantitative diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(10): 732-735. doi: 10.3969/j.issn.1001-5256.2013.10.003 |
[17] | Zhao ChunHua, Zhou WenFeng, Chen WeiHua, Xi Zhen, Zhang ChunMei. Clinical significance of α- fetoprotein in initial diagnosis of primary hepatic cancer[J]. Journal of Clinical Hepatology, 2013, 29(9): 698-701. doi: 10.3969/j.issn.1001-5256.2013.09.017 |
[18] | Liang Liang, Lu XiuLiang, Gu JunYing, Chen Gang, Rao ShengXiang, Ji Yuan, Ceng MengSu. Imaging characteristics of abdominal organs in autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2012, 28(8): 579-583. |
[19] | Liu Qin, Qiao XiuLi, Gao XiaoZhong, Shao ChunZhong. The importance of regular follow-up for early detection of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2010, 26(3): 306-307+309. |